Figure 1. An immunohistochemistry panel for low grade TCC (Ta) [a, EN2 positive (+3); b, CD73 negative (0); c, Ki67 positive; and d, p63 positive (+1) X 200], showed recurrence before 6 months with progression to high grade TCC (T2)

From

The Combined Role of EN2, CD73 and KI67 in Predicting Recurrence and Progression of Non-muscle Invasive Bladder Cancer

Yomna A. Zamzam, Aymen M. El-Saka, Ahmed M. El-Saka, Hassan El-Tatawy

Journal of Cancer Research and Treatment. 2017, 5(3), 92-99 doi:10.12691/jcrt-5-3-4